Nuvation Bio NUVB Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.4M+115% | -$36.59M+34.4% | -$55.79M+5.4% | -$59.01M-10.8% | -$53.24M-7.7% | ||
| $536K-0.6% | $539K+0.9% | $534K+50.0% | $356K+14.8% | $310K+41.6% | ||
| $9.03M+13.1% | $7.99M-0.4% | $8.02M-33.3% | $12.03M+53.2% | $7.85M-22.9% | ||
| $5.07M+117% | -$29.73M+43.8% | -$52.89M-9.8% | -$48.18M-13.0% | -$42.63M+7.9% | ||
| $48K— | $0-100% | $7.75M+4,180% | $181K+151% | $72K— | ||
| -$43.64M-150% | $87.08M— | —— | $54.88M+1.3% | $54.18M+4.7% | ||
| $44K-99.5% | $8.06M+1,509% | $501K-99.7% | $193.42M+35,196% | $548K— | ||
| -$38.7M-159% | $65.19M— | —— | $199.99M+1,532% | $12.25M— | ||
| $5.02M+117% | -$29.73M+51.0% | -$60.64M-25.4% | -$48.36M-13.3% | -$42.7M+7.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Nuvation Bio generate?
- Nuvation Bio (NUVB) generated -$125.7M in operating cash flow over the trailing twelve months.
- What is Nuvation Bio's free cash flow?
- After $8.0M of capital expenditures, Nuvation Bio's free cash flow was -$133.7M over the trailing twelve months, up 15.0% year over year.
- Where does Nuvation Bio's cash flow data come from?
- Every line is extracted from Nuvation Bio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
